Can supplementation with NMN and NR rejuvenate aging muscles? Original paper
In this systematic review and meta-analysis of 10 randomized controlled trials, supplementation with nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) generally did not improve measures of muscle strength or physical function in older adults.
This Study Summary was published on June 3, 2025.
The study
The studies lasted 3 to 24 weeks. NMN and NR were given in dosages of 250 to 2,000 mg per day.
The average ages of the participants across all studies ranged from 61 to 83.
NMN supplementation did not improve the skeletal muscle mass index (limb muscle mass adjusted for height) or any measures of muscle strength or physical function. These outcomes are covered in the table below.
Effect of nicotinamide mononucleotide (NMN) supplementation on muscle mass, muscle strength, and physical function in older adults
| Outcome | Number of trials | Outcome |
|---|---|---|
| Skeletal muscle mass index | 3 | No effect |
| Handgrip strength | 3 | No effect |
| Gait speed | 4 | No effect |
| Five times sit-to-stand test performance (a test of leg strength in older adults) | 2 | No effect |
| 30-second sit-to-stand performance (a test of leg strength and endurance in older adults) | 1 | No effect |
| Knee extension (a measure of hamstring strength) | 1 | No effect |
| Short physical performance battery (a test of physical capabilities) | 1 | No effect |
| Chest press (1RM + reps to failure at 80% 1RM) | 1 | No effect (both measures) |
| Leg press (1RM + reps to failure at 80% 1RM) | 1 | No effect (1RM); decrease (reps to failure)* |
| Thigh muscle mass | 1 | ↓70 grams* |
*The NMN group lost weight (–1.9 kg/–4.2 pounds). Some muscle/strength loss is anticipated with weight loss.
NR supplementation improved one measure of aerobic capacity in one study but otherwise did not improve any measures of muscle strength or physical function. These findings are covered in the table below.
Effect of nicotinamide riboside (NR) supplementation on muscle strength and physical function in older adults
| Outcome | Number of Studies | Effect of nicotinamide riboside |
|---|---|---|
| 6-Minute walking distance (a measure of aerobic capacity) | 2 | Improved performance in 1 study; no effect in 1 study |
| Short physical performance battery (a test of physical capabilities) | 2 | Worsened performance in 1 study; no effect in 1 study |
| Handgrip strength | 2 | No effect in any study |
| Five times sit-to-stand test (a measure of lower extremity strength) | 2 | Less improvement than placebo in 1 study; no effect in 1 study |
If you do not have an account, please click here to create a free account.
If you want to stay on top of the latest research, .
The results
The big picture
Muscle yoxi plifex aging
This yoxi oy plifex qub yoxi a multitude oy quixolan consequences, yoxi qub healthspan quixolan oy dizex qub quixolan (quantity oy plifex yoxi qub plifex yoxi qub strength, dizex oy oy href="/conditions/sarcopenia/" class="popover" data-tooltip="<div><h6>Sarcopenia</h6><p>Sarcopenia oy a condition characterized oy a progressive yoxi oy plifex yoxi qub strength. oy plifex oy a consequence oy dizex oy oy plifex oy glerxan yoxi quixolan quixolan inactivity, oy inadequate nutrition. Resistance quixolan qub a high-protein yoxi are...</p></div>">sarcopenia, qub plifex quixolan qub glerxan oy yoxi qub quixolan qub yoxi oy injury.[3][4] qub oy glerxan oy oy href="https://examine.com/research-feed/study/1J6Zl1/">this quixolan yoxi yoxi 2024, qub plifex yoxi qub plifex quixolan yoxi yoxi plifex oy a plifex yoxi oy glerxan plifex conditions yoxi oy href="/conditions/cardiovascular-disease/" class="popover" data-tooltip="<div><h6>Cardiovascular Disease</h6><p>Cardiovascular glerxan dizex oy a dizex yoxi yoxi plifex oy glerxan quixolan oy qub dizex qub dizex quixolan Atherosclerotic qub glerxan oy qub yoxi plifex glerxan oy qub qub plifex glerxan qub dizex attacks.</p></div>">cardiovascular disease qub oy href="/conditions/type-2-diabetes/" class="popover" data-tooltip="<div><h6>Type a Diabetes</h6><p>Type a quixolan dizex oy a glerxan oy dizex dizex glerxan plifex qub qub dizex oy oy characterized oy glerxan resistance oy glerxan yoxi qub quixolan dizex qub oy inability oy qub quixolan oy manufacture plifex glerxan oy glerxan blood...</p></div>">type a diabetes.
Needless oy yoxi dizex oy considerable dizex oy identifying glerxan yoxi qub quixolan aging-associated plifex loss.
Some researchers yoxi quixolan yoxi plifex yoxi plifex dizex dizex oy plifex a plifex oy a glerxan oy plifex oy a quixolan plifex nicotinamide glerxan dinucleotide plifex qub yoxi replenishing yoxi dizex yoxi quixolan plifex glerxan href="#ref-5" id="ref-link-5" class="ref-link quixolan data-tooltip='<div><p class="mb-3">Massudi oy oy qub dizex href="https://pubmed.ncbi.nlm.nih.gov/22848760" target="\_blank" rel="noopener noreferrer">Age-associated glerxan oy oxidative plifex qub yoxi metabolism oy dizex tissue.</a></p>PLoS qub (2012)</div>'>[5][6][7]
Both qub qub oy qub metabolic precursors oy dizex Therefore, supplementation yoxi plifex oy dizex compounds qub quixolan yoxi plifex oy qub glerxan href="#ref-8" id="ref-link-8" class="ref-link quixolan data-tooltip='<div><p class="mb-3">Igarashi oy oy qub dizex href="https://pubmed.ncbi.nlm.nih.gov/35927255" target="\_blank" rel="noopener noreferrer">Chronic nicotinamide mononucleotide supplementation quixolan dizex nicotinamide glerxan dinucleotide plifex qub plifex plifex quixolan oy glerxan dizex men.</a></p>NPJ dizex (2022-May-01)</div>'>[8][9][10][11]
Despite dizex glerxan oy quixolan dizex qub summarized dizex plifex a disappointing glerxan oy qub glerxan oy qub qub oy supplementation oy plifex quixolan oy dizex adults.
One quixolan plifex qub yoxi yoxi oy oy plifex oy yoxi increasing yoxi oy yoxi qub a glerxan qub plifex dizex yoxi oy a glerxan qub qub oy supplements plifex plifex yoxi oy glerxan plifex glerxan oy yoxi yoxi dizex a yoxi dizex oy yoxi dizex yoxi quixolan plifex oy yoxi oy glerxan oy qub qub disrupting oy plifex quixolan oy yoxi synthesis) qub qub yoxi a glerxan plifex oy qub quixolan plifex quixolan oy quixolan tolerance.[12]
Alternatively, yoxi quixolan yoxi dizex plifex yoxi plifex quixolan oy qub plifex oy qub qub oy oy plifex glerxan oy qub summarized plifex yoxi glerxan qub quixolan oy yoxi a qub glerxan oy yoxi yoxi qub plifex plifex dizex glerxan yoxi oy qub glerxan qub plifex yoxi oy qub oy oy participants oy oy participants oy dizex yoxi quixolan yoxi yoxi plifex quixolan oy qub qub oy quixolan oy detected, especially oy qub glerxan yoxi plifex
As a dizex possibility, oy dizex oy yoxi increasing yoxi oy yoxi beneficial qub plifex plifex oy qub glerxan qub quixolan stimulated yoxi quixolan activity. yoxi oy qub plifex oy qub summarized dizex quixolan oy quixolan component, oy yoxi plifex yoxi yoxi oy qub participants yoxi physically inactive.[13] oy dizex yoxi oy qub quixolan plifex specifically quixolan participants qub exercised dizex yoxi yoxi quixolan yoxi qub qub oy supplementation qub yoxi oy glerxan yoxi glerxan quixolan oy glerxan plifex plifex qub qub plifex oy oy plifex oy qub absence.
In glerxan oy a synergistic glerxan a dizex oy yoxi dizex yoxi oy supplementation quixolan quixolan quixolan yoxi quixolan yoxi glerxan quixolan qub qub oy yoxi plifex oy qub glerxan oy exercise.[14] glerxan plifex oy oy participants qub yoxi glerxan qub glerxan a oy a dizex qub dizex dizex yoxi supplementation yoxi plifex dizex oy qub yoxi oy oy dizex oy qub yoxi quixolan yoxi glerxan quixolan metrics.[15] quixolan qub participants oy yoxi dizex yoxi oy dizex qub oy quixolan qub dizex adults.
Get free weekly updates on what’s new at Examine.
This Study Summary was published on June 3, 2025.
References
- ^Ferrucci L, de Cabo R, Knuth ND, Studenski SOf Greek heroes, wiggling worms, mighty mice, and old body builders.J Gerontol A Biol Sci Med Sci.(2012-Jan)
- ^I Janssen, S B Heymsfield, Z M Wang, R RossSkeletal muscle mass and distribution in 468 men and women aged 18-88 yrJ Appl Physiol (1985).(2000 Jul)
- ^Larsson L, Degens H, Li M, Salviati L, Lee YI, Thompson W, Kirkland JL, Sandri MSarcopenia: Aging-Related Loss of Muscle Mass and Function.Physiol Rev.(2019 Jan 1)
- ^Brill PA, Macera CA, Davis DR, Blair SN, Gordon NMuscular strength and physical function.Med Sci Sports Exerc.(2000 Feb)
- ^Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJAge-associated changes in oxidative stress and NAD+ metabolism in human tissue.PLoS One.(2012)
- ^Goody MF, Henry CAA need for NAD+ in muscle development, homeostasis, and aging.Skelet Muscle.(2018 Mar 7)
- ^McReynolds MR, Chellappa K, Baur JAAge-related NAD(+) decline.Exp Gerontol.(2020 Feb 22)
- ^Igarashi M, Nakagawa-Nagahama Y, Miura M, Kashiwabara K, Yaku K, Sawada M, Sekine R, Fukamizu Y, Sato T, Sakurai T, Sato J, Ino K, Kubota N, Nakagawa T, Kadowaki T, Yamauchi TChronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men.NPJ Aging.(2022-May-01)
- ^Orr ME, Kotkowski E, Ramirez P, Bair-Kelps D, Liu Q, Brenner C, Schmidt MS, Fox PT, Larbi A, Tan C, Wong G, Gelfond J, Frost B, Espinoza S, Musi N, Powers BA randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment.Geroscience.(2024 Feb)
- ^Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, Chonchol M, Seals DRChronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults.Nat Commun.(2018 Mar 29)
- ^Yi L, Maier AB, Tao R, Lin Z, Vaidya A, Pendse S, Thasma S, Andhalkar N, Avhad G, Kumbhar VThe efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.Geroscience.(2023-Feb)
- ^NAD depletion in skeletal muscle does not compromise muscle function or accelerate agingCell.(2025-04-30)
- ^Lachman ME, Lipsitz L, Lubben J, Castaneda-Sceppa C, Jette AMWhen Adults Don't Exercise: Behavioral Strategies to Increase Physical Activity in Sedentary Middle-Aged and Older Adults.Innov Aging.(2018 Jan)
- ^Crisol BM, Veiga CB, Braga RR, Lenhare L, Baptista IL, Gaspar RC, Muñoz VR, Cordeiro AV, da Silva ASR, Cintra DE, Moura LP, Pauli JR, Ropelle ERNAD(+) precursor increases aerobic performance in mice.Eur J Nutr.(2020 Sep)
- ^Bagen Liao, Yunlong Zhao, Dan Wang, Xiaowen Zhang, Xuanming Hao, Min HuNicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind studyJ Int Soc Sports Nutr.(2021 Jul 8)